Pre–Drug-Eluting Stent Debulking of Bifurcated Coronary Lesions
Etsuo Tsuchikane, MD, PhD*,*,
Tadanori Aizawa, MD ,
Hideo Tamai, MD ,
Yasumi Igarashi, MD ,
Kenji Kawajiri, MD||,
Noriyuki Ozawa, MD¶,
Shigeru Nakamura, MD#,
Koji Oku, MD**,
Mikihiro Kijima, MD ,
Takahiko Suzuki, MD* for the PERFECT Investigators
* Department of Cardiology, Toyohashi Heart Center, Aichi, Japan
Department of Cardiology, The Cardiovascular Institute Hospital, Tokyo, Japan
Department of Cardiology, Kusatsu Heart Center, Kusatsu, Japan
Department of Cardiology, Sapporo City General Hospital, Sapporo, Japan
|| Department of Cardiology, Matsubara Tokushukai Hospital, Osaka, Japan
¶ Department of Cardiology, Yokohama Asahi General Hospital, Kanagawa, Japan
# Department of Cardiology, Kyoto Katsura Hospital, Kyoto, Japan
** Department of Cardiology, Nagasaki Medical Center, Nagasaki, Japan
 Department of Medicine, Hoshi General Hospital, Fukushima, Japan.

View larger version (31K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Stenting Strategies
(A) Crossover stenting. The stent is placed in the main branch (MB) covering the side branch (SB) after directional coronary atherectomy (DCA) debulking. It was followed by kissing balloon technique (KBT) or balloon angioplasty (BA) for the SB when necessary. (B) Noncrossover stenting. Plaque debulking by DCA is performed in the MB. The stent is then placed in the MB ostium without covering the SB.
|
|
|